Literature DB >> 25947172

Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent.

Mercedes Perusquía1, Clayton D Greenway2, Lisa M Perkins2, John N Stallone3.   

Abstract

Testosterone (TES) and other androgens exert a direct vasorelaxing action on the vasculature in vitro that is structurally specific and independent of cytosolic androgen receptor (AR). The effects of intravenous androgen infusions on mean arterial blood pressure (BP) and heart rate (HR) were determined in conscious, unrestrained, chronically catheterized, ganglionically blocked (hexamethonium, HEX; 30 mg/kg ip) male Sprague-Dawley (SD) and testicular-feminized male (Tfm; AR-deficient) rats, 16-20 wk of age. BP and HR were recorded at baseline and with increasing doses of androgens (0.375-6.00 μmol·kg(-1)·min(-1) iv; 10 min/dose). Data are expressed as means ± SE (n = 5-8 rats/group). In SD rats, baseline BP and HR averaged 103 ± 4 mmHg and 353 ± 12 beats/min (bpm). TES produced a dose-dependent reduction in BP to a low of 87 ± 4 mmHg (Δ16%), while HR was unchanged (354 ± 14 bpm). Neither BP (109 ± 3 mmHg) nor HR (395 ± 13 bpm) were altered by vehicle (10% EtOH in 0.9% saline; 0.15 ml·kg(-1)·min(-1), iv). In Tfm, TES produced a similar reduction in BP (99 ± 3 to 86 ± 3 mmHg, Δ13%); HR was unchanged (369 ± 18 bpm). In SD, 5β-dihydrotestosterone (genomically inactive metabolite) produced a greater reduction in BP than TES (102 ± 2 to 79 ± 2 mmHg, Δ23%); HR was unchanged (361 ± 9). A 20-μg iv bolus of sodium nitroprusside in both SD and Tfm rats reduced BP 30-40 mmHg, while HR was unchanged, confirming blockade by HEX. Pretreatment of SD rats with neuronal nitric oxide synthase (nNOS) inhibitor (S-methyl-thiocitrulline, SMTC; 20 μg·kg(-1)·min(-1) × 30 min) abolished the hypotensive effects of TES infusion on BP (104 ± 2 vs. 101 ± 2 mmHg) and HR (326 ± 11 vs. 324 ± 8 bpm). These data suggest the systemic hypotensive effect of TES and other androgens involves a direct vasodilatory action on the peripheral vasculature which, like the effect observed in isolated arteries, is structurally specific and AR-independent, and involves activation of nNOS.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  5β-DHT; blood pressure; neuronal NOS; testosterone; vasodilation

Mesh:

Substances:

Year:  2015        PMID: 25947172      PMCID: PMC4504958          DOI: 10.1152/ajpregu.00110.2015

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  50 in total

1.  Serum testosterone levels and arterial blood pressure in the elderly.

Authors:  Roberto Fogari; Paola Preti; Annalisa Zoppi; Elena Fogari; Andrea Rinaldi; Luca Corradi; Amedeo Mugellini
Journal:  Hypertens Res       Date:  2005-08       Impact factor: 3.872

Review 2.  Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites.

Authors:  Mercedes Perusquía; John N Stallone
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-12       Impact factor: 4.733

3.  Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED.

Authors:  Giovanni Corona; Edoardo Mannucci; Francesco Lotti; Alessandra D Fisher; Elisa Bandini; Giancarlo Balercia; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2009-01       Impact factor: 3.802

4.  The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.

Authors:  P Mårin; S Holmäng; L Jönsson; L Sjöström; H Kvist; G Holm; G Lindstedt; P Björntorp
Journal:  Int J Obes Relat Metab Disord       Date:  1992-12

5.  Relaxation of androgens on rat thoracic aorta: testosterone concentration dependent agonist/antagonist L-type Ca2+ channel activity, and 5beta-dihydrotestosterone restricted to L-type Ca2+ channel blockade.

Authors:  Luis M Montaño; Eduardo Calixto; Alejandra Figueroa; Edgar Flores-Soto; Verónica Carbajal; Mercedes Perusquía
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

6.  Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations.

Authors:  K O Rowell; J Hall; P J Pugh; T H Jones; K S Channer; R D Jones
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

7.  Effects of testosterone supplementation in the aging male.

Authors:  J S Tenover
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

8.  Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study.

Authors:  Johan Svartberg; Denise von Mühlen; Henrik Schirmer; Elizabeth Barrett-Connor; Johan Sundfjord; Rolf Jorde
Journal:  Eur J Endocrinol       Date:  2004-01       Impact factor: 6.664

Review 9.  Testosterone and coronary artery disease.

Authors:  J Nettleship; R Jones; K Channer; T Jones
Journal:  Front Horm Res       Date:  2009       Impact factor: 2.606

Review 10.  The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.

Authors:  Abdulmaged M Traish; Andre Guay; Robert Feeley; Farid Saad
Journal:  J Androl       Date:  2008-07-17
View more
  8 in total

Review 1.  Disorders of Sexual Development in Adult Women.

Authors:  Veronica Gomez-Lobo; Anne-Marie Amies Oelschlager
Journal:  Obstet Gynecol       Date:  2016-11       Impact factor: 7.661

2.  Hypotestosteronemia is an important factor for the development of hypertension: elevated blood pressure in orchidectomized conscious rats is reversed by different androgens.

Authors:  Mercedes Perusquía; Daniela Contreras; Nieves Herrera
Journal:  Endocrine       Date:  2019-06-15       Impact factor: 3.633

Review 3.  Testosterone, myocardial function, and mortality.

Authors:  Vittorio Emanuele Bianchi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 4.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

5.  Cardiovascular and Metabolic Consequences of Testosterone Supplements in Young and Old Male Spontaneously Hypertensive Rats: Implications for Testosterone Supplements in Men.

Authors:  Carolina Dalmasso; Chetan N Patil; Licy L Yanes Cardozo; Damian G Romero; Rodrigo O Maranon
Journal:  J Am Heart Assoc       Date:  2017-10-17       Impact factor: 5.501

Review 6.  Trials of testosterone replacement reporting cardiovascular adverse events.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Asian J Androl       Date:  2018 Mar-Apr       Impact factor: 3.285

7.  Hypogonadal hypertension in male Sprague-Dawley rats is renin-angiotensin system-dependent: role of endogenous androgens.

Authors:  Andrea E Hanson; Mercedes Perusquia; John N Stallone
Journal:  Biol Sex Differ       Date:  2020-08-26       Impact factor: 5.027

8.  Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities.

Authors:  Molly M Shores; Thomas J Walsh; Anna Korpak; Chloe Krakauer; Christopher W Forsberg; Alexandra E Fox; Kathryn P Moore; Susan R Heckbert; Mary Lou Thompson; Nicholas L Smith; Alvin M Matsumoto
Journal:  J Am Heart Assoc       Date:  2021-08-21       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.